Logos Global Management LP Dice Therapeutics, Inc. Transaction History

Logos Global Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $6.51 Million - $8.08 Million	-250,000 Reduced 37.88%	410,000 $11.7 Million
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $8.41 Million - $18 Million	-425,251 Reduced 39.18%	660,000 $20.6 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $1.5 Million - $2.27 Million	100,000 Added 10.15%	1,085,251 $22 Million
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $5.28 Million - $8.84 Million	-400,000 Reduced 28.88%	985,251 $15.3 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $4.06 Million - $6.98 Million	-279,000 Reduced 16.76%	1,385,251 $26.5 Million
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $11.3 Million - $18.9 Million	504,000 Added 43.44%	1,664,251 $42.1 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $37 Million - $42.9 Million	1,160,251 New	1,160,251 $38 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.